We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+32.24%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$145M
AUM Growth
+$19.4M
Cap. Flow
-$9.46M
Cap. Flow %
-6.51%
Top 10 Hldgs %
80.75%
Holding
47
New
9
Increased
8
Reduced
5
Closed
7

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$5.87M
2
AMZN icon
Amazon
AMZN
+$2.77M
3
ANIP icon
ANI Pharmaceuticals
ANIP
+$1.86M
4
MON
Monsanto Co
MON
+$1.58M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$824K

Top Sells

Rank Stock Value
1
AKRX
Akorn Inc
AKRX
+$3.76M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$2.38M
3
BMY icon
Bristol-Myers Squibb
BMY
+$2.21M
4
INSY
Insys Therapeutics, Inc.
INSY
+$1.84M
5
CRM icon
Salesforce
CRM
+$1.59M

Sector Composition

Rank Sector Weight
1 Healthcare 60.02%
2 Consumer Discretionary 16.28%
3 Communication Services 12.76%
4 Financials 5.47%
5 Materials 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$36.8M 25.34%
525,755
+276
+0.1% +$15.3K
AMZN icon
2
Amazon
AMZN
$2.48T
$19.8M 13.61%
472,260
+72,260
+18% +$2.77M
ARLZ
3
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$12.7M 8.73%
2,615,140
-122,000
-4% -$556K
META icon
4
Meta Platforms (Facebook)
META
$1.51T
$11.9M 8.21%
93,000
– –
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$9.19M 6.33%
507,075
-122,000
-19% -$2.38M
BX icon
6
Blackstone
BX
$104B
$7.53M 5.19%
295,009
– –
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$4.12T
$6.03M 4.15%
+150,000
New +$5.87M
AVDL
8
DELISTED
Avadel Pharmaceuticals
AVDL
$5.51M 3.79%
444,439
– –
LGND icon
9
Ligand Pharmaceuticals
LGND
$5.79B
$4.41M 3.03%
69,208
+11,221
+19% +$824K
WING icon
10
Wingstop
WING
$3.84B
$3.4M 2.34%
116,057
– –
BSTC
11
DELISTED
BioSpecifics Technologies Corp.
BSTC
$3.32M 2.28%
72,649
– –
QLTI
12
DELISTED
QLT Inc
QLTI
$3.28M 2.26%
1,592,993
– –
ISRG icon
13
Intuitive Surgical
ISRG
$127B
$2.17M 1.5%
27,000
+4,500
+20% +$345K
UNH icon
14
UnitedHealth
UNH
$385B
$2.1M 1.45%
15,000
– –
ANIP icon
15
ANI Pharmaceuticals
ANIP
$1.84B
$1.97M 1.36%
+29,722
New +$1.86M
JNP
16
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$1.82M 1.25%
328,132
– –
CBM
17
DELISTED
Cambrex Corporation
CBM
$1.8M 1.24%
40,519
+5,371
+15% +$261K
AKRX
18
DELISTED
Akorn Inc
AKRX
$1.58M 1.09%
57,871
-127,127
-69% -$3.76M
MON
19
DELISTED
Monsanto Co
MON
$1.54M 1.06%
+15,100
New +$1.58M
ASRT
20
DELISTED
Assertio
ASRT
$1.45M 1%
965
– –
ATRS
21
DELISTED
Antares Pharma, Inc.
ATRS
$1.41M 0.97%
840,625
+364,728
+77% +$447K
MLM icon
22
Martin Marietta Materials
MLM
$34.2B
$896K 0.62%
5,000
+2,000
+67% +$382K
ADVM
23
DELISTED
Adverum Biotechnologies
ADVM
$781K 0.54%
18,992
– –
GRPN icon
24
Groupon
GRPN
$1.07B
$569K 0.39%
+5,520
New +$538K
STRR
25
DELISTED
Star Equity Holdings
STRR
$562K 0.39%
2,205
– –
1
2

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q3 2016 Portfolio in Review

As of Q3 2016, JW Asset Management held 47 positions worth $145M, up 15% from $126M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

JW Asset Management withdrew a net $9.46M in Q3 2016, closing 7 positions and reducing 5 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $2.21M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 54% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, JW Asset Management opened a new position in Alphabet (Google) Class A worth $6.03M.

  • JW Asset Management's largest Q3 2016 buy was Alphabet (Google) Class A: 150,000 shares worth $6.03M.
  • JW Asset Management added most to Amazon in Q3 2016, an estimated $2.77M increase.
  • JW Asset Management's biggest Q3 2016 reduction was Akorn Inc, cutting an estimated $3.76M.
  • JW Asset Management fully exited Bristol-Myers Squibb in Q3 2016, selling an estimated $2.21M.
  • JW Asset Management's ten largest holdings make up 81% of its $145M portfolio in Q3 2016.
  • JW Asset Management opened 9 new positions and closed 7 in Q3 2016.
  • JW Asset Management's portfolio value rose 15% quarter-over-quarter to $145M.

Based on JW Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.